Collection and Storage of Biological Samples Obtained by Leukapheresis for the Future Study of Immune Responses After BCG Vaccination in BCG-naive Healthy Adults in the US (A-046)
Phase of Trial: Phase 0
Latest Information Update: 14 Oct 2015
At a glance
- Drugs AERAS 422 (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- Sponsors Aeras
- 08 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 May 2015 Planned initiation date changed from 1 Apr 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.